Plasma asymmetric dimethylarginine (ADMA) in pediatric patients with cystic fibrosis (CF)

被引:0
|
作者
Lucca, Francesca
Ros, Mirco
Piazza, Vanna
Gucciardi, Antonina
Giordano, Giuseppe
Da Dalt, Liviana
Baraldi, Eugenio
机构
关键词
Cystic fibrosis; Children; Inflammation;
D O I
10.1183/13993003.congress-2016.PA1003
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
PA1003
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes
    Tsikas, Dimitrios
    Bollenbach, Alexander
    Hanff, Erik
    Kayacelebi, Arslan Arinc
    CARDIOVASCULAR DIABETOLOGY, 2018, 17
  • [42] Plasma concentrations of asymmetric dimethylarginine (ADMA) in Colombian women with pre-eclampsia
    Maas, R
    Böger, RH
    Schwedhelm, E
    Casas, JP
    López-Jaramillo, P
    Serrano, N
    Díaz, LA
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (07): : 823 - 824
  • [43] Plasma Concentrations of Asymmetric Dimethylarginine (ADMA) Predict LV Mass Independent of Afterload
    Sverdlov, Aaron L.
    Ngo, Doan T.
    Nightingale, Angus K.
    Rajendran, Sharmalar
    Heresztyn, Tamila
    Horowitz, John D.
    CIRCULATION, 2009, 120 (18) : S806 - S806
  • [44] Smoking is associated with increased plasma asymmetric dimethylarginine (ADMA) levels in patients with type 2 diabetes mellitus
    Fard, A
    Bryant, TA
    Tuck, CH
    Vest, JA
    Sciacca, R
    Di Tullio, MR
    Chen, NT
    Berglund, L
    Ginsberg, HN
    Homma, S
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 327A - 327A
  • [45] Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease
    Wang, J
    Sim, AS
    Wang, XL
    Salonikas, C
    Naidoo, D
    Wilcken, DEL
    ATHEROSCLEROSIS, 2006, 184 (02) : 383 - 388
  • [46] Elevated plasma asymmetric dimethylarginine (ADMA) and graft failure in cardiac transplant recipients
    Fard, A
    Eisenberg, M
    Morrow, JP
    Sciacca, RR
    Chen, HJ
    Mancini, DM
    Edwards, NM
    Rabbani, LE
    Cannon, P
    CIRCULATION, 2000, 102 (18) : 374 - 375
  • [47] ANALYSIS OF ASYMMETRIC DIMETHYLARGININE (ADMA) IN CHILDREN WITH HYPERTENSION
    Zaniew, M.
    Blumczynski, A.
    Mrozinski, B.
    Lewandowska-Stachowiak, M.
    Zachwieja, J.
    JOURNAL OF HYPERTENSION, 2009, 27 : S204 - S204
  • [48] Asymmetric Dimethylarginine (ADMA) in cardiovascular and renal disease
    Alpoim, Patricia Nessralla
    Nunes Sousa, Leticia Parreiras
    Lucas Mota, Ana Paula
    Alves Rios, Danyelle Romana
    SantAna Dusse, Luci Maria
    CLINICA CHIMICA ACTA, 2015, 440 : 36 - 39
  • [49] Asymmetric dimethylarginine (ADMA): an endogenous inhibitor of angiogenesis
    John P. Cooke
    European Journal of Clinical Pharmacology, 2006, 62 : 115 - 121
  • [50] Increased plasma asymmetric dimethylarginine (ADMA) levels in retinal venous occlusive disease
    Zinellu, Angelo
    Pinna, Antonio
    Sotgia, Salvatore
    Zinellu, Elisabetta
    FrancaUsai, Maria
    Carta, Francesco
    Gaspa, Leonardo
    Deiana, Luca
    Carru, Ciriaco
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2008, 46 (03) : 387 - 392